<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">The Immunoregulator Soluble TACI Is Released by ADAM10 and Reflects B Cell Activation in Autoimmunity</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Franziska</forename><forename type="middle">S</forename><surname>Hoffmann</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Clinical Neuroimmunology</orgName>
								<orgName type="institution">Ludwig Maximilian University</orgName>
								<address>
									<postCode>D-81377</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peer-Hendrik</forename><surname>Kuhn</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution" key="instit1">Neuroproteomics</orgName>
								<orgName type="institution" key="instit2">Technical University Munich and Hospital Rechts der Isar</orgName>
								<address>
									<postCode>D-81675</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">German Center for Neurodegenerative Diseases</orgName>
								<address>
									<postCode>D-53175</postCode>
									<settlement>Bonn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Institute for Advanced Study</orgName>
								<orgName type="institution">Technical University</orgName>
								<address>
									<postCode>D-85748</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department" key="dep1">Department of Neurology</orgName>
								<orgName type="department" key="dep2">Department of Rheumatology and Clinical Immunology</orgName>
								<orgName type="institution">Ludwig Maximilian University</orgName>
								<address>
									<postCode>D-81377</postCode>
									<settlement>Munich, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="department">Department of Cancer Biology</orgName>
								<orgName type="institution">Charite ´-University Medicine Berlin</orgName>
								<address>
									<postCode>D-10117</postCode>
									<settlement>Berlin</settlement>
									<country>Germany; xx</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="institution">Mayo Clinic Florida</orgName>
								<address>
									<postCode>32224</postCode>
									<settlement>Jacksonville</settlement>
									<region>FL</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sarah</forename><forename type="middle">A</forename><surname>Laurent</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Clinical Neuroimmunology</orgName>
								<orgName type="institution">Ludwig Maximilian University</orgName>
								<address>
									<postCode>D-81377</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stefanie</forename><forename type="middle">M</forename><surname>Hauck</surname></persName>
							<affiliation key="aff5">
								<orgName type="institution" key="instit1">Research Unit Protein Science</orgName>
								<orgName type="institution" key="instit2">Helmholtz Center Munich</orgName>
								<orgName type="institution" key="instit3">German Research Center for Environmental Health</orgName>
								<address>
									<postCode>D-85764</postCode>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kerstin</forename><surname>Berer</surname></persName>
							<affiliation key="aff6">
								<orgName type="department" key="dep1">Department of Neuroimmunology</orgName>
								<orgName type="department" key="dep2">Max Planck Institute of Neurobiology</orgName>
								<address>
									<postCode>D-82152</postCode>
									<settlement>Martinsried</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Simone</forename><forename type="middle">A</forename><surname>Wendlinger</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Clinical Neuroimmunology</orgName>
								<orgName type="institution">Ludwig Maximilian University</orgName>
								<address>
									<postCode>D-81377</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Markus</forename><surname>Krumbholz</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Clinical Neuroimmunology</orgName>
								<orgName type="institution">Ludwig Maximilian University</orgName>
								<address>
									<postCode>D-81377</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mohsen</forename><surname>Khademi</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Division of Clinical Neuroscience</orgName>
								<orgName type="institution">Karolinska University Hospital</orgName>
								<address>
									<postCode>14186</postCode>
									<settlement>Stockholm</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tomas</forename><surname>Olsson</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Division of Clinical Neuroscience</orgName>
								<orgName type="institution">Karolinska University Hospital</orgName>
								<address>
									<postCode>14186</postCode>
									<settlement>Stockholm</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Martin</forename><surname>Dreyling</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Department of Medicine III</orgName>
								<orgName type="institution">Ludwig Maximilian University</orgName>
								<address>
									<postCode>D-81377</postCode>
									<settlement>Munich</settlement>
									<country>Germany; †</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hans-Walter</forename><surname>Pfister</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution" key="instit1">Neuroproteomics</orgName>
								<orgName type="institution" key="instit2">Technical University Munich and Hospital Rechts der Isar</orgName>
								<address>
									<postCode>D-81675</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department" key="dep1">Department of Neurology</orgName>
								<orgName type="department" key="dep2">Department of Rheumatology and Clinical Immunology</orgName>
								<orgName type="institution">Ludwig Maximilian University</orgName>
								<address>
									<postCode>D-81377</postCode>
									<settlement>Munich, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="department">Department of Cancer Biology</orgName>
								<orgName type="institution">Charite ´-University Medicine Berlin</orgName>
								<address>
									<postCode>D-10117</postCode>
									<settlement>Berlin</settlement>
									<country>Germany; xx</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="institution">Mayo Clinic Florida</orgName>
								<address>
									<postCode>32224</postCode>
									<settlement>Jacksonville</settlement>
									<region>FL</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tobias</forename><surname>Alexander</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution" key="instit1">Neuroproteomics</orgName>
								<orgName type="institution" key="instit2">Technical University Munich and Hospital Rechts der Isar</orgName>
								<address>
									<postCode>D-81675</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">German Center for Neurodegenerative Diseases</orgName>
								<address>
									<postCode>D-53175</postCode>
									<settlement>Bonn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department" key="dep1">Department of Neurology</orgName>
								<orgName type="department" key="dep2">Department of Rheumatology and Clinical Immunology</orgName>
								<orgName type="institution">Ludwig Maximilian University</orgName>
								<address>
									<postCode>D-81377</postCode>
									<settlement>Munich, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="department">Department of Cancer Biology</orgName>
								<orgName type="institution">Charite ´-University Medicine Berlin</orgName>
								<address>
									<postCode>D-10117</postCode>
									<settlement>Berlin</settlement>
									<country>Germany; xx</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="institution">Mayo Clinic Florida</orgName>
								<address>
									<postCode>32224</postCode>
									<settlement>Jacksonville</settlement>
									<region>FL</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Falk</forename><surname>Hiepe</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">German Center for Neurodegenerative Diseases</orgName>
								<address>
									<postCode>D-53175</postCode>
									<settlement>Bonn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tania</forename><surname>K€</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Clinical Neuroimmunology</orgName>
								<orgName type="institution">Ludwig Maximilian University</orgName>
								<address>
									<postCode>D-81377</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">German Center for Neurodegenerative Diseases</orgName>
								<address>
									<postCode>D-53175</postCode>
									<settlement>Bonn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Howard</forename><forename type="middle">C</forename><surname>Crawford</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">German Center for Neurodegenerative Diseases</orgName>
								<address>
									<postCode>D-53175</postCode>
									<settlement>Bonn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hartmut</forename><surname>Wekerle</surname></persName>
							<affiliation key="aff6">
								<orgName type="department" key="dep1">Department of Neuroimmunology</orgName>
								<orgName type="department" key="dep2">Max Planck Institute of Neurobiology</orgName>
								<address>
									<postCode>D-82152</postCode>
									<settlement>Martinsried</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Reinhard</forename><surname>Hohlfeld</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Clinical Neuroimmunology</orgName>
								<orgName type="institution">Ludwig Maximilian University</orgName>
								<address>
									<postCode>D-81377</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="institution" key="instit1">Research Unit Protein Science</orgName>
								<orgName type="institution" key="instit2">Helmholtz Center Munich</orgName>
								<orgName type="institution" key="instit3">German Research Center for Environmental Health</orgName>
								<address>
									<postCode>D-85764</postCode>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>{{</roleName><forename type="first">Stefan</forename><forename type="middle">F</forename><surname>Lichtenthaler</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution" key="instit1">Neuroproteomics</orgName>
								<orgName type="institution" key="instit2">Technical University Munich and Hospital Rechts der Isar</orgName>
								<address>
									<postCode>D-81675</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">German Center for Neurodegenerative Diseases</orgName>
								<address>
									<postCode>D-53175</postCode>
									<settlement>Bonn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="institution" key="instit1">Research Unit Protein Science</orgName>
								<orgName type="institution" key="instit2">Helmholtz Center Munich</orgName>
								<orgName type="institution" key="instit3">German Research Center for Environmental Health</orgName>
								<address>
									<postCode>D-85764</postCode>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department" key="dep1">Department of Neurology</orgName>
								<orgName type="department" key="dep2">Department of Rheumatology and Clinical Immunology</orgName>
								<orgName type="institution">Ludwig Maximilian University</orgName>
								<address>
									<postCode>D-81377</postCode>
									<settlement>Munich, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="department">Department of Cancer Biology</orgName>
								<orgName type="institution">Charite ´-University Medicine Berlin</orgName>
								<address>
									<postCode>D-10117</postCode>
									<settlement>Berlin</settlement>
									<country>Germany; xx</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="institution">Mayo Clinic Florida</orgName>
								<address>
									<postCode>32224</postCode>
									<settlement>Jacksonville</settlement>
									<region>FL</region>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><roleName>{{</roleName><forename type="first">Edgar</forename><surname>Meinl</surname></persName>
							<email>edgar.meinl@med.uni-muenchen.de</email>
							<affiliation key="aff1">
								<orgName type="department">Institute of Clinical Neuroimmunology</orgName>
								<orgName type="institution">Ludwig Maximilian University</orgName>
								<address>
									<postCode>D-81377</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="institution" key="instit1">Research Unit Protein Science</orgName>
								<orgName type="institution" key="instit2">Helmholtz Center Munich</orgName>
								<orgName type="institution" key="instit3">German Research Center for Environmental Health</orgName>
								<address>
									<postCode>D-85764</postCode>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>Prof</roleName><forename type="middle">Edgar</forename><surname>Meinl</surname></persName>
							<affiliation key="aff5">
								<orgName type="institution" key="instit1">Research Unit Protein Science</orgName>
								<orgName type="institution" key="instit2">Helmholtz Center Munich</orgName>
								<orgName type="institution" key="instit3">German Research Center for Environmental Health</orgName>
								<address>
									<postCode>D-85764</postCode>
									<settlement>Neuherberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="institution">The American Association of Immunologists, Inc</orgName>
								<address>
									<addrLine>Suite 650</addrLine>
									<postCode>1451, 20852</postCode>
									<settlement>Rockville Pike, Rockville</settlement>
									<region>MD</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff12">
								<orgName type="department">{{ Munich Cluster for Systems Neurology (SyNergy)</orgName>
								<address>
									<postCode>D-81377</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff13">
								<orgName type="department">Institute of Clinical Neuroimmunology</orgName>
								<orgName type="institution">Ludwig Maximilian University</orgName>
								<address>
									<addrLine>Marchioninistrasse 15</addrLine>
									<postCode>D-81377</postCode>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">The Immunoregulator Soluble TACI Is Released by ADAM10 and Reflects B Cell Activation in Autoimmunity</title>
					</analytic>
					<monogr>
						<idno type="ISSN">0022-1767</idno>
					</monogr>
					<idno type="MD5">06C257DF88E53879DAE481313BE628A9</idno>
					<idno type="DOI">10.4049/jimmunol.1402070</idno>
					<note type="submission">Received for publication August 13, 2014. Accepted for publication October 30, 2014.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:13+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>APRIL, a proliferation-inducing ligand</term>
					<term>BCMA, B cell maturation Ag</term>
					<term>CIS, clinically isolated syndrome</term>
					<term>CRD, cysteine-rich domain</term>
					<term>CSF, cerebrospinal fluid</term>
					<term>CTF, C-terminal fragment</term>
					<term>IP, immunoprecipitation</term>
					<term>MS, multiple sclerosis</term>
					<term>NB, neuroborreliosis</term>
					<term>NP-40, Nonidet P-40</term>
					<term>OND, other neurologic disease</term>
					<term>PVDF, polyvinylidene difluoride</term>
					<term>RR-MS, relapsing-remitting multiple sclerosis</term>
					<term>shRNA, short hairpin RNA</term>
					<term>SLE, systemic lupus erythematosus</term>
					<term>SP-MS, secondary progressive multiple sclerosis</term>
					<term>sTACI, soluble TACI</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>BAFF and a proliferation-inducing ligand (APRIL), which control B cell homeostasis, are therapeutic targets in autoimmune diseases.</s><s>TACI-Fc (atacicept), a soluble fusion protein containing the extracellular domain of the BAFF-APRIL receptor TACI, was applied in clinical trials.</s><s>However, disease activity in multiple sclerosis unexpectedly increased, whereas in systemic lupus erythematosus, atacicept was beneficial.</s><s>In this study, we show that an endogenous soluble TACI (sTACI) exists in vivo.</s><s>TACI proteolysis involved shedding by a disintegrin and metalloproteinase 10 releasing sTACI from activated B cells.</s><s>The membrane-bound stub was subsequently cleaved by g-secretase reducing ligand-independent signaling of the remaining C-terminal fragment.</s><s>The shed ectodomain assembled ligand independently in a homotypic way.</s><s>It functioned as a decoy receptor inhibiting BAFF-and APRIL-mediated B cell survival and NF-kB activation.</s><s>We determined sTACI levels in autoimmune diseases with established hyperactivation of the BAFF-APRIL system.</s><s>sTACI levels were elevated both in the cerebrospinal fluid of the brain-restricted autoimmune disease multiple sclerosis correlating with intrathecal IgG production, as well as in the serum of the systemic autoimmune disease systemic lupus erythematosus correlating with disease activity.</s><s>Together, we show that TACI is sequentially processed by a disintegrin and metalloproteinase 10 and g-secretase.</s><s>The released sTACI is an immunoregulator that shares decoy functions with atacicept.</s><s>It reflects systemic and compartmentalized B cell accumulation and activation.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>B</head><p><s>cells play a significant role in the pathogenesis of autoimmunity and B cell modulating therapies are promising in the treatment of a variety of autoimmune diseases <ref type="bibr" target="#b0">(1)</ref>.</s><s>Regulation of B cell homeostasis involves the BAFF-APRIL system that is comprised of two ligands, BAFF and a proliferationinducing ligand (APRIL), and three receptors, B cell maturation Ag (BCMA), transmembrane activator and CAML interactor (TACI), and BAFF receptor <ref type="bibr" target="#b1">(2)</ref>.</s></p><p><s>In systemic lupus erythematosus (SLE), an involvement of the BAFF-APRIL axis is prominent, as mice overexpressing BAFF develop an SLE-like phenotype, BAFF is elevated in the serum of SLE patients, and the mAb belimumab targeting BAFF is beneficial in a proportion of SLE patients <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b3">4)</ref>.</s><s>In multiple sclerosis (MS), an organ-specific autoimmune disease characterized by local Ig production with long-term persistence of B cells in the CNS <ref type="bibr" target="#b4">(5,</ref><ref type="bibr" target="#b5">6)</ref>, BAFF is upregulated in MS plaques and is produced by astrocytes <ref type="bibr" target="#b6">(7)</ref>.</s><s>Although depletion of B cells in MS with anti-CD20 Abs is promising <ref type="bibr" target="#b7">(8)</ref>, targeting the B cell survival factors BAFF and APRIL with atacicept, a recombinant fusion protein containing the extracellular ligand-binding portion of TACI linked to the Fc domain of human IgG, unexpectedly increased disease activity in MS patients <ref type="bibr" target="#b8">(9)</ref>, whereas in SLE atacicept was beneficial at least at a high dose <ref type="bibr" target="#b9">(10)</ref>.</s></p><p><s>TACI is a type I-oriented transmembrane protein belonging to the TNFR superfamily.</s><s>It is expressed on CD27 + memory B cells, plasma cells and a subpopulation of CD27 2 B cells and is induced early upon B cell activation <ref type="bibr" target="#b10">(11)</ref>.</s><s>The ectodomain of TACI contains two cysteine-rich domains (CRDs).</s><s>The first CRD is involved in ligand-independent assembly of TACI into multimeric complexes, whereas the second CRD is required for binding of BAFF and APRIL <ref type="bibr" target="#b11">(12)</ref>.</s><s>Ligand binding to TACI recruits signaling molecules to the intracellular domain of TACI, which leads to activation of NFAT and NF-kB <ref type="bibr" target="#b12">(13,</ref><ref type="bibr" target="#b13">14)</ref>.</s><s>Studies of TACI 2/2 mice showed that this receptor is both a positive and negative regulator of B cell responses <ref type="bibr" target="#b14">(15)</ref><ref type="bibr" target="#b15">(16)</ref><ref type="bibr" target="#b16">(17)</ref>.</s><s>Mutations in TACI are a cause of common variable immunodeficiency and IgA deficiency <ref type="bibr" target="#b17">(18,</ref><ref type="bibr" target="#b18">19)</ref>.</s><s>However, some of these patients in addition develop signs of autoimmunity and lymphoproliferation <ref type="bibr" target="#b18">(19)</ref>.</s></p><p><s>Importantly, the functions of some transmembrane receptors extend beyond signal transmission, as they can be processed into soluble receptors <ref type="bibr" target="#b19">(20)</ref>.</s><s>In this regard, proteases of the a disintegrin and metalloproteinase (ADAM) family are involved in ectodomain shedding of a variety of membrane proteins <ref type="bibr" target="#b20">(21)</ref>.</s><s>This can modulate signaling activity either by downregulation of membrane-bound receptors or by the release of soluble receptors like soluble TNFR1 <ref type="bibr" target="#b21">(22)</ref> or soluble IL-6R <ref type="bibr" target="#b22">(23)</ref>.</s><s>In the case of type I transmembrane proteins, the g-secretase complex may further cleave the remaining fragment within the plasma membrane <ref type="bibr" target="#b23">(24)</ref> in a process called regulated intramembrane proteolysis <ref type="bibr" target="#b24">(25)</ref>.</s></p><p><s>In this study, we show that the TACI extracellular domain is shed from activated B cells by ADAM10, giving rise to soluble TACI (sTACI).</s><s>The remaining C-terminal fragment (CTF) is cleaved by g-secretase.</s><s>sTACI assembles homotypically; it binds BAFF and APRIL to block NF-kB activation and B cell survival.</s><s>In systemic (SLE) and compartmentalized (MS) immunopathologies, we detected elevated levels of sTACI establishing sTACI as a potential biomarker.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Plasmids</head><p><s>Human TACI in pCMV6-XL4, human BCMA in pCMV6-XL5, and the control vector pCMV6-AN-DDK were purchased from Origene Technologies.</s><s>TACI with a C-terminal FLAG-tag, TACI with an N-terminal FLAGtag (TACI-N-FLAG), and TACI with an N-terminal hemagglutinin tag (TACI-N-HA) were added in pcDNA3.1 using standard cloning procedures.</s><s>To generate TACI lacking the ectodomain (TACI-D-Ecto), the TACI sequence coding for aa 155-293 was cloned into pcDNA3.1.</s><s>CRE followed by the T2A peptide sequence and GFP or GFP alone were cloned into the retroviral vector pMSCV.</s><s>The pCL-Eco packaging construct was additionally used for retrovirus production.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Protease inhibitors</head><p><s>DAPT (Merck Calbiochem), TAPI-1 (Merck Calbiochem), C3 (Merck Calbiochem), and GI254023X (kindly provided by Dr. Andreas Ludwig, University of Erlangen, Erlangen, Germany) were used.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell culture</head><p><s>Raji cells were cultured in RPMI 1640 (Sigma-Aldrich)/10% FBS (Biochrom AG)/100 U/ml penicillin plus 100 mg/ml streptomycin (Life Technologies, Invitrogen)/1% nonessential amino acids (Life Technologies, Invitrogen)/1 mM sodium pyruvate (Life Technologies, Invitrogen)/ 2 mM L-glutamine (Pan Biotech).</s><s>HEK293T cells were cultured in DMEM (Sigma-Aldrich)/10% FBS/100 U/ml penicillin plus 100 mg/ml streptomycin.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Transient transfection</head><p><s>HEK293T cells were transfected using Lipofectamine 2000 (Invitrogen).</s><s>sTACI containing and control supernatants were generated by transfection of 10 mg TACI in pCMV-XL4 or an empty vector.</s><s>After 3 d, supernatants were harvested and centrifuged two times at 400 3 g for 7 min and one time at 20,000 3 g for 30 min.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Human B cell culture and stimulation</head><p><s>PBMCs were isolated by density gradient separation using Pancoll (Pan Biotech).</s><s>Human B cells were isolated by negative selection using the EasySep Human B Cell Enrichment Kit (StemCell Technologies).</s><s>Human B cells were seeded at 8 3 10 5 cells/ml and activated using ODN 2006 (2.5 mg/ml; Invivogen), anti-IgM (10 mg/ml Jackson ImmunoResearch Laboratories), R848 (1 mg/ml; Sigma-Aldrich), recombinant human IL-2 (25 ng/ml; R&amp;D Systems), coculture with CD40L expressing mouse L cells (5 3 10 4 cells/ml), and recombinant human IL-21 (50 ng/ml; eBioscience).</s><s>Supernatants were collected after 4 d.</s><s>sTACI production and IgG production were measured.</s><s>TACI surface expression was determined using a PE mouse anti-human TACI Ab (5 mg/ml; clone FAB1741P; R&amp;D Systems) and the corresponding PE mouse IgG1 isotype control (5 mg/ml; clone X40; BD Biosciences).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Murine B cell culture and survival assay</head><p><s>For murine B cell cultivation, spleens from C57BL/6 mice (8-12 wk of age) were passed over a 40-mm cell strainer.</s><s>Red cell lysis was performed using ACK buffer (150 mM NH 4 Cl, 10 mM KHCO 3 , and 0.1 mM EDTA) for 2 min on ice.</s><s>B cells were isolated using the EasySep Mouse B Cell Isolation Kit (StemCell Technologies) by negative selection.</s><s>The murine B cells were seeded at a concentration of 3 3 10 6 cells/ml on cellculture plates coated with anti-murine IgM Abs (2.5 mg/ml) overnight at room temperature.</s><s>Cells were treated with the indicated concentrations of HEK293T cell supernatants containing sTACI and control supernatants generated as described above.</s><s>Additionally, TACI-Fc was added (R&amp;D Systems), and cells were stimulated with BAFF (100 ng/ml; R&amp;D Systems) and APRIL (100 ng/ml; AdipoGen).</s><s>After 2 d of cultivation, mouse B cells were analyzed by flow cytometry using a PE anti-mouse CD19 Ab (1 mg/ml; clone MB19-1; eBioscience) and APC TO-PRO-3 Iodide (250 nM; Life Technologies).</s><s>PE-positive and allophycocyanin-negative cells were determined.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Western blotting and immunoprecipitation</head><p><s>To analyze the role of g-secretase, TACI with a C-terminal FLAG-tag was transfected into HEK293T cells using Lipofectamine 2000 (Invitrogen).</s><s>Increasing amounts of DAPT were added.</s><s>After 48 h, cells were lysed in Nonidet P-40 (NP-40) buffer (150 mM NaCl, 50 mM Tris [pH 7.5], 1% NP-40, and complete protease inhibitor mixture; Roche Applied Science).</s><s>Proteins were electrophoresed on 10-20% Tricine gels, transferred to polyvinylidene difluoride (PVDF) membranes, and blotted with an anti-FLAG Ab (clone M2; Sigma-Aldrich).</s><s>To control for equal protein loading, membranes were stained with anti-b-actin Ab (clone C4; Santa Cruz Biotechnology).</s><s>For immunoprecipitation (IP) of sTACI from HEK293T, a monoclonal mouse anti-TACI Ab (clone MAB174; R&amp;D Systems) or a mouse IgG1 control (R&amp;D Systems) was used.</s><s>For IP from Raji cell supernatant, the polyclonal goat anti-TACI Ab (clone AF174; R&amp;D Systems) or a goat IgG control (R&amp;D Systems) was applied.</s><s>Abs were coupled to Dynabeads Protein G (Life Technologies) and cross-linked with bis-sulfosuccinimidylsuberate (Pierce).</s><s>sTACI derived from HEK293T cells was eluted with NuPAGE LDS Sample Buffer (Life Technologies), electrophoresed on 4-12% Bis-Tris gels (Life Technologies) with MES-running buffer, blotted on PVDF membranes, and stained with a monoclonal mouse anti-TACI Ab (clone MAB174; R&amp;D Systems).</s><s>Alternatively, the PVDF membrane was cut prior to staining at the height corresponding to sTACI, and N-terminal sequencing was performed.</s><s>sTACI derived from RAJI cells was obtained by acidic elution.</s><s>For coimmunoprecipitation of TACI-N-HA and TACI-N-FLAG, HEK293T cells were transfected with the respective expression constructs.</s><s>Forty-eight hours later, cells and supernatants were harvested.</s><s>Cells were lysed in IP buffer (0.5% NP-40, 50 mM HEPES, 250 mM NaCl, 5 mM EDTA, and complete protease inhibitor mixture; Roche Applied Science).</s><s>IP was performed using anti-FLAG magnetic beads (Sigma-Aldrich).</s><s>IP eluates and pre-IP samples were subjected to ELISA.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Mass spectrometry and Edman sequencing</head><p><s>sTACI derived from Raji cells was digested in solution with trypsin or GluC; sTACI derived from HEK293T cells was digested with trypsin and chymotrypsin.</s><s>Mass spectrometry (LTQ Orbitrap XL; Thermo Scientific) was performed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ELISA</head><p><s>Human sTACI and IgG concentrations were determined using the Human TACI DuoSet (DY174; R&amp;D Systems) and the Human IgG ELISA development kit (Mabtech), respectively.</s><s>Complex formation between sTACI and BAFF and APRIL was determined by coating anti-FLAG Ab (M2; 5 mg/ml; Sigma-Aldrich) on ELISA plates, incubating them with BAFF-FLAG (Enzo Life Sciences) and APRIL-FLAG (AdipoGen) (200 ng/ml) and adding sTACI and TACI-Fc (R&amp;D Systems) (25 ng/ml).</s><s>Bound TACI was detected using the TACI DuoSet ELISA Kit.</s><s>To detect TACI-N-HA coimmunoprecipitated with TACI-N-FLAG, ELISA plates were coated with an anti-HA.11</s><s>(Covance) Ab (5 mg/ml).</s><s>The following ELISA steps were performed using the TACI DuoSet ELISA Kit (R&amp;D Systems).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>NF-kB reporter assay</head><p><s>HEK293T cells were cotransfected with a firefly luciferase reporter plasmid, the internal control CMV Renilla luciferase plasmid, and the respective expression plasmids.</s><s>The decoy-function of sTACI was assessed by adding BAFF or APRIL-FLAG (100 ng/ml) to supernatants containing sTACI or to control supernatants.</s><s>After incubation at 37˚C for 30 min, supernatants were added to the BCMA-transfected cells.</s><s>Sixteen hours later, cells were lysed with passive lysis buffer (Promega), and reporter gene activity was determined using firefly luciferase substrate (Biozym) and Renilla luciferase substrate (Promega), respectively.</s><s>To analyze the role of g-secretase on NF-kB activation, TACI-D-Ekto or full-length TACI was transfected together with the above-described luciferase plasmids.</s><s>Eight hours after transfection, DAPT and BAFF were added.</s><s>Sixteen hours later, NF-kB-activation was measured as described.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Retrovirus production and transduction of B cells from ADAM10 conditional knockout mice</head><p><s>We isolated splenic B cells from ADAM10 conditional knockout mice <ref type="bibr" target="#b25">(26)</ref>, which contain two flox sites flanking the ADAM10 gene.</s><s>Mouse B cells were stimulated for 2 d with CpG ODN 1668 20 mg/ml (Invivogen) and rCD40L 2.5 mg/ml (R&amp;D Systems).</s><s>Retrovirus was produced as described previously (27) using the vector pMSCV expressing GFP or the CRErecombinase followed by the sequence of the self-cleaving T2A peptide and GFP.</s><s>B cells were spin-infected as described previously <ref type="bibr" target="#b26">(27)</ref>.</s><s>On day 4, TACI expression was determined using a rat monoclonal anti-mouse TACI Ab (clone FAB1041A; 5 mg/ml; R&amp;D Systems).</s><s>Knockdown of ADAM10 was determined by Western blot using a rabbit monoclonal anti-ADAM10 Ab (clone EPR5622; Abcam) in FACS-sorted GFP-positive cells.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Lentiviral short hairpin RNA-mediated knockdown</head><p><s>Lentivirus production was performed as described previously <ref type="bibr" target="#b27">(28)</ref>.</s><s>Short hairpin RNA (shRNA) sequences are listed in Supplemental Table <ref type="table">1</ref>.</s><s>Raji cells were plated at 1 3 10 6 cells/ml and transfected with conditioned medium containing the lentiviruses.</s><s>The transduced Raji cells were plated at 5 3 10 5 cells/ml.</s><s>Twenty-four hours later, supernatants were harvested and analyzed for sTACI concentration by ELISA.</s><s>TACI surface expression was determined by FACS using a mouse monoclonal anti-TACI Ab (clone MAB174; 1 mg/ml; R&amp;D Systems) and the corresponding mouse IgG1 isotype control (R&amp;D Systems).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Real-time PCR</head><p><s>RNA from transduced Raji cells was isolated using the RNeasy Micro Kit (Qiagen).</s><s>cDNA was generated using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems).</s><s>For real-time PCR, TaqMan assays for ADAM10 and ADAM17 (Applied Biosystems) and PrimeTime qPCR Assays for ADAM9 and ADAM19 (Integrated DNA Technologies) were used in combination with the TaqMan PCR Core Reagent Kit (Applied Biosystems).</s><s>Cyclophilin (Applied Biosystems) expression was determined as a housekeeping gene.</s><s>Samples were run in MicroAmp Optical 96-well reaction plates (Applied Biosystems) in a 7900HT Fast Real-Time PCR System (Applied Biosystems).</s><s>Data was analyzed using SDSv2.3</s><s>software (Applied Biosystems).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistics</head><p><s>Statistical significance was assessed with Prism Software (GraphPad) by unpaired or paired, nonparametric, or parametric t test analysis or by Spearman correlation, as appropriate.</s><s>The p values *p , 0.05, **p , 0.01, ***p , 0.001, and ****p , 0.0001 were considered significant and designated accordingly.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>sTACI is released by activated B cells</head><p><s>As TACI is described as an ambivalent regulator of B cell homeostasis, we speculated that this effect could be due to a soluble variant of TACI.</s><s>Therefore, we stimulated primary human B cells with a panel of different B cell activators and determined plasma membrane expression of TACI (Fig. <ref type="figure" target="#fig_1">1A</ref>) and in parallel release of sTACI (Fig <ref type="figure" target="#fig_1">1B</ref>).</s><s>Although B cells in human blood expressed little TACI on their surface, we noted a strong induction by TLR7/8 and TLR9 agonists and by CD40L, which was further enhanced by addition of IL-21 (Fig. <ref type="figure" target="#fig_1">1A</ref>) <ref type="bibr" target="#b10">(11)</ref>.</s><s>sTACI release and TACI surface expression, induced by the different stimuli, correlated strongly (Fig. <ref type="figure" target="#fig_1">1C</ref>), suggesting that sTACI production by primary B cells parallels levels of TACI on the cell surface.</s><s>In addition, we analyzed whether sTACI release is linked to differentiation into Ig-secreting cells.</s><s>We found that activated B cells released sTACI without producing IgG (e.g., after CD40L and R848 stimulation) (Fig. <ref type="figure" target="#fig_1">1B</ref>).</s><s>To identify stimuli that trigger sTACI release from membrane-bound TACI, we stimulated the Burkitt lymphoma cell line Raji, which endogenously expresses TACI, with different TLR ligands and cytokines (polyinosinic-polycytidylic acid, CpG ODN 2006, TNF-a, IFN-g, and PMA).</s><s>We did not observe a strong modulation of sTACI release (Supplemental Fig. <ref type="figure" target="#fig_1">1A</ref>), and only PMA weakly and transiently induced TACI shedding (Supplemental Fig. <ref type="figure" target="#fig_1">1B</ref>).</s><s>Thus, when TACI is present on the cell surface, it is shed without the need of an additional stimulus.</s><s>Together, this suggests that sTACI release reflects TACI expression on the cell surface.</s><s>sTACI represents the extracellular part of TACI Next, we determined the m.w. and amino acid composition of sTACI.</s><s>We immunoprecipitated sTACI from the supernatant of HEK293T cells that had been transfected with full-length human TACI.</s><s>sTACI had a molecular mass of ∼13 kDa in Western blot analysis and silver staining (Fig. <ref type="figure" target="#fig_2">2A</ref>).</s><s>For mass spectrometry, we analyzed the band detected by silver staining and sTACI immunoprecipitated from Raji cell supernatant.</s><s>After trypsin, chymotrypsin, and GluC digestion as well as N-terminal sequencing, we found soluble TACI to be composed of the extracellular part of TACI (Fig. <ref type="figure" target="#fig_2">2B</ref>).</s><s>The sequence at the C terminus ended with K154, adjacent to L155 in sTACI derived from HEK293T cells and Raji cells (Fig. <ref type="figure" target="#fig_2">2B</ref>).</s><s>K154/ L155 is within the juxtamembrane region and comprises a typical cleavage motif of metalloproteinases of the ADAM and membranetype matrix metalloproteinases family <ref type="bibr" target="#b27">(28)</ref>.</s><s>Therefore, K154/L155 could be the naturally occurring cleavage site of TACI resulting in generation of sTACI.</s><s>Alternatively, this site can also be recognized by trypsin.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ADAM10 sheds TACI</head><p><s>To identify the protease that sheds TACI, we applied different protease inhibitors to Raji cells.</s><s>We found that the metalloproteinase inhibitor TAPI-1, as well as GI254023X (29), a specific ADAM10 inhibitor, blocked sTACI release and increased surface expression of TACI (Fig. <ref type="figure" target="#fig_3">3A, 3B</ref>).</s><s>The b-secretase inhibitor C3 <ref type="bibr" target="#b29">(30)</ref> and the g-secretase inhibitor DAPT had no effect (Fig. <ref type="figure" target="#fig_3">3A, 3B</ref>).</s><s>A combined treatment with TAPI-1 and GI254023X did not further decrease sTACI production (Fig. <ref type="figure" target="#fig_3">3A</ref>), suggesting that besides ADAM10 no other protease susceptible to inhibition by TAPI-1 is involved in TACI cleavage.</s><s>TAPI-1 also reduced the release of sTACI from primary human B cells activated with CD40L and IL-21, whereas DAPT had no effect (Supplemental Fig. <ref type="figure" target="#fig_1">1C</ref>).</s><s>To confirm the role of ADAM10 in TACI cleavage, we lentivirally transduced Raji cells with shRNAs targeting ADAM9, ADAM10, ADAM17, and ADAM19 (Fig. <ref type="figure" target="#fig_3">3C,  3D</ref>).</s><s>As knockdown of ADAM17 influenced cell survival and proliferation, we corrected sTACI levels for cell number.</s><s>Knockdown was confirmed by quantitative PCR (Fig. <ref type="figure" target="#fig_3">3E</ref>).</s><s>We found that only a knockdown of ADAM10 led to a decrease of sTACI production (Fig. <ref type="figure" target="#fig_3">3D</ref>), paralleled by an increase of TACI surface expression (Fig. <ref type="figure" target="#fig_3">3C</ref>).</s><s>None of the other applied shRNAs influenced membranebound TACI or sTACI production (Fig. <ref type="figure" target="#fig_3">3C, 3D</ref>).</s><s>The effect mediated by ADAM10 shRNA was similar to that of TAPI-1 in ELISA and FACS (Fig. <ref type="figure" target="#fig_3">3A, 3B</ref>).</s><s>To confirm the role of ADAM10 in TACI shedding in primary B cells, we used murine B cells from conditional ADAM10 KO mice that contain two flox sites flanking the ADAM10 gene <ref type="bibr" target="#b25">(26)</ref>.</s><s>To achieve the ADAM10 knockout, B cells were transduced with retroviral particles expressing the CRErecombinase followed by the self-cleaving T2A peptide <ref type="bibr" target="#b30">(31)</ref> and GFP (CRE-T2A-GFP), which resulted in efficient knockout of ADAM10 as confirmed by Western blot (Supplemental Fig. <ref type="figure" target="#fig_2">2A</ref>).</s><s>As a control, a retrovirus expressing GFP was used.</s><s>TACI expression was determined by FACS.</s><s>Knockout of ADAM10 led to an increase of TACI surface expression when comparing cells transduced with the control virus to cells transduced with the CRE-T2A-GFP virus (Supplemental Fig. <ref type="figure" target="#fig_2">2B</ref>) and also when GFP-positive cells were compared with GFP-negative cells after transduction with the CRE-T2A-GFP virus (Supplemental Fig. <ref type="figure" target="#fig_2">2C-E</ref>).</s><s>This shows that ADAM10 also sheds TACI from primary murine B cells.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>g-Secretase cleaves the CTF of TACI</head><p><s>As ectodomain shedding of type I membrane proteins is commonly followed by g-secretase cleavage of the CTF (25), we investigated whether g-secretase is also involved in the cleavage of the TACI CTF.</s><s>When we transfected TACI with a C-terminal FLAG-tag in HEK293T cells and treated them with DAPT, we observed accumulation of the TACI CTF (Fig. <ref type="figure" target="#fig_4">4A</ref>), which demonstrates that the CTF of TACI is cleaved by g-secretase.</s><s>As a next step, we investigated potential functional consequences of TACI-cleavage by g-secretase.</s><s>We used an NF-kB reporter assay in HEK293T cells transfected with either full-length human TACI (TACI-FL) or TACI-D-Ecto resembling the TACI CTF.</s><s>Both TACI-FL and TACI-D-Ecto exhibited constitutive NF-kB activation in the absence of a ligand (Fig. <ref type="figure" target="#fig_4">4B</ref>).</s><s>Spontaneous dimerization via the CRD1 ( <ref type="formula">12</ref>) is believed to confer constitutive activity to TACI.</s><s>TACI-D-Ecto lacks the CRD1.</s><s>The CTF might therefore dimerize independent of the CRD1 due to high amounts of TACI present in this overexpression system.</s><s>Additionally, we stimulated the transfected cells with BAFF.</s><s>As expected, BAFF increased NF-kB activation in cells transfected with TACI-FL, but did not activate TACI-D-Ecto, which lacks the ligand binding domain (Fig. <ref type="figure" target="#fig_4">4B</ref>).</s><s>DAPT treatment increased NF-kB signaling mediated by TACI-D-Ecto, indicating that cleavage of the CTF of TACI by g-secretase reduces NF-kB activation.</s><s>This suggests that g-secretase cleavage of TACI CTF might be relevant to limit NF-kB activation after TACI ectodomain shedding.</s><s>DAPT treatment had no effect on cells transfected with TACI-FL presumably because the amount of TACI cleaved by ADAM10 compared with TACI-FL was too low.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>sTACI assembles in homotypic interaction</head><p><s>To establish whether sTACI exists as a monomeric or an oligomeric form, we coexpressed TACI-N-HA or TACI-N-FLAG in HEK293T cells.</s><s>We found that sTACI-N-HA could be coimmunoprecipitated with sTACI-N-FLAG, which argues for a homotypic interaction of sTACI monomers in the absence of ligand (Fig. <ref type="figure">5A</ref>).</s><s>As a positive control, full-length TACI-N-HA derived from cell lysates was coimmunoprecipitated with full-length TACI-N-FLAG, because membrane-bound TACI was reported previously to interact homotypically (12) (Fig. <ref type="figure">5B</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>sTACI binds BAFF and APRIL, blocking B cell survival and NF-kB activation</head><p><s>To explore the function of sTACI generated after ADAM10 cleavage, we determined binding of sTACI to BAFF and APRIL.</s><s>We established an ELISA in which sTACI was captured by BAFF-FLAG or APRIL-FLAG immobilized on an anti-FLAG-coated ELISA plate.</s><s>We found that sTACI as well as TACI-Fc bound both BAFF and APRIL (Fig. <ref type="figure">6A</ref>).</s><s>In the following, we evaluated the functional consequences of this binding and determined the influence of sTACI on BCMA-mediated NF-kB activation in the presence of BAFF and The Journal of Immunology APRIL in HEK293T cells.</s><s>In our assay, transfection of BCMA leads to lower constitutive activity and higher activation after stimulation compared with TACI transfection and was therefore more suitable for testing a possible decoy function of sTACI.</s><s>Addition of sTACI to APRIL and BAFF-stimulated cells dose-dependently blocked NF-kB activation (Fig. <ref type="figure">6B</ref>).</s><s>BAFF-mediated NF-kB activation could be blocked slightly more efficiently (Fig. <ref type="figure">6B</ref>).</s><s>Recombinant TACI-Fc was used as a control and exhibited comparable blocking capacity as sTACI (Fig. <ref type="figure">6B</ref>).</s><s>To further support the functional relevance of sTACI, we tested the impact of sTACI  <ref type="figure">FIGURE 5</ref>. sTACI assembles homotypically independent of a ligand.</s><s>(A and B) HEK293T cells were transfected with expression plasmids containing TACI with an N-terminal FLAG-tag or HA-tag as indicated.</s><s>Forty-eight hours after transfection, supernatants (A) were harvested, and cell lysates (B) were prepared.</s><s>A part of the supernatants (A) and lysates (B) prior to IP were stored; the remaining supernatants and lysates were subjected to FLAG-IP, and the IP eluates plus the supernatants and lysates stored prior to IP were measured by ELISA.</s><s>An anti-HA Ab was used for coating, and an anti-TACI Ab was applied for detection; combined data of three independent experiments (mean 6 SEM).</s><s>on survival of primary B cells.</s><s>We purified mouse B cells from spleens and stimulated them with anti-IgM plus BAFF or APRIL and increasing concentrations of sTACI.</s><s>BAFF increased B cell survival more strongly than APRIL.</s><s>This enhanced survival by both ligands could efficiently be blocked by sTACI and TACI-Fc (Fig. <ref type="figure">6C</ref>).</s><s>These data point to a negative regulatory function of sTACI on B cell survival.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>sTACI as a potential biomarker in human immunopathologies</head><p><s>We evaluated whether sTACI is detectable in: 1) inflammatory CNS diseases with compartmentalized IgG production (MS and neuroborreliosis [NB]); and 2) a systemic autoimmune disease (SLE).</s><s>We found significantly increased sTACI levels in the cerebrospinal fluid (CSF) of MS patients compared with patients with ONDs without signs of CNS inflammation (Fig. <ref type="figure" target="#fig_5">7A</ref>).</s><s>Moreover, sTACI levels correlated strongly with intrathecal IgG production (Fig. <ref type="figure" target="#fig_5">7B</ref>).</s><s>This correlation was confirmed in a second cohort of 25 MS patients (p , 0.0001; r = 0.82).</s><s>We investigated whether this elevation is specific for MS or a consequence of compartmentalized inflammation in the brain.</s><s>Therefore, we analyzed patients with NB, which is like MS characterized by intrathecal IgG production.</s><s>We detected elevation of sTACI and correlation to intrathecal IgG production also in NB, which suggests that increased sTACI levels in the CSF are not disease specific, but the consequence of local accumulation and activation of B cells.</s><s>In contrast to CSF, in plasma, no significant difference between patients with MS and ONDs was detected (Supplemental Fig. <ref type="figure" target="#fig_3">3A</ref>).</s><s>sTACI levels in CSF did not differ among CIS, RR-MS, and SP-MS patients (Supplemental Fig. <ref type="figure" target="#fig_3">3B</ref>).</s><s>Immunosuppressive treatment <ref type="bibr">FIGURE 6</ref>. sTACI acts as a decoy for BAFF and APRIL and blocks B cell survival.</s><s>(A) ELISA plates were coated with anti-FLAG Abs (M2; 5 mg/ml); BAFF-FLAG and APRIL-FLAG were added; and sTACI (25 ng/ml) derived from supernatant of transfected HEK293T cells or concentrated supernatants of Raji cells and TACI-Fc (25 ng/ml) were used; combined data of three independent experiments (mean 6 SEM).</s><s>(B) HEK293T cells were transfected with full-length BCMA (2.5 ng) and a luciferase-based NF-kB reporter.</s><s>BAFF and APRIL (100 ng/ml) were added together with increasing amounts of sTACIcontaining supernatant (33, 100, and 300 ng/ml), control supernatant, or TACI-Fc (300 ng/ml), and NF-kB activation was determined (two-tailed, paired t test); combined data of three independent experiments (mean 6 SEM).</s><s>(C) Murine B cells were activated via anti-IgM and cultured for 2 d with APRIL or BAFF (100 ng/ml) in the presence or absence of sTACI (100, 200, and 400 ng/ml) and TACI-Fc (400 ng/ml).</s><s>Survival of B cells was determined by FACS analyzing the percentage of living CD19 + cells after staining with TO-PRO-3 iodide.</s><s>Viability was calculated in relation to the BAFF-and APRIL-induced survival that was assigned as 1 (two-tailed, paired t test between BAFF-treated and BAFF + sTACI/TACI-Fc-treated conditions); combined data of four to five independent experiments (mean 6 SEM).</s><s>*p , 0.05, **p , 0.01, ***p , 0.001.</s></p><p><s>The Journal of Immunology influenced sTACI levels, as we found decreased sTACI levels in the CSF of MS patients 12 mo after initiation of monthly i.v.</s><s>natalizumab treatment (Fig. <ref type="figure" target="#fig_5">7C</ref>).</s><s>Furthermore, sTACI levels were transiently reduced 3 d after corticosteroid treatment and returned to baseline levels within a period of 4 wk (Supplemental Fig. <ref type="figure" target="#fig_3">3C</ref>).</s><s>In SLE, we found significantly increased sTACI levels in untreated patients compared with healthy control patients (Fig. <ref type="figure" target="#fig_5">7D</ref>), which decreased upon treatment (Fig. <ref type="figure" target="#fig_5">7D</ref>).</s><s>Interestingly, sTACI levels in untreated patients correlated with disease activity as expressed by the SLE Disease Activity Index (Fig. <ref type="figure" target="#fig_5">7E</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>In this study, we report that the membrane-bound BAFF-APRIL receptor TACI undergoes ectodomain shedding by ADAM10 and consecutive cleavage by g-secretase.</s><s>Shedding of TACI was a consequence of membrane expression of TACI on activated B cells.</s><s>The generation of soluble receptors is a common principle involving a variety of membrane proteins like growth factors, receptors and their ligands, cytokines, and cell adhesion molecules <ref type="bibr" target="#b19">(20,</ref><ref type="bibr" target="#b20">21)</ref>.</s><s>We identified ADAM10 as the sheddase releasing sTACI, whereas the prototype of this superfamily, TNFR1, is shed by ADAM17 <ref type="bibr" target="#b31">(32)</ref>.</s><s>ADAM10 is believed to be mainly involved in the constitutive shedding of membrane proteins, whereas ADAM17 can be activated by PMA <ref type="bibr" target="#b32">(33)</ref>.</s><s>Consistent with this principle, we found ADAM10dependent sTACI production to mainly reflect TACI expression on the cell surface and observed only little induction of shedding by PMA.</s></p><p><s>TACI shedding was followed by g-secretase cleavage of the remaining membrane stub representing the CTF.</s><s>It is unclear whether cleavage of TACI by g-secretase solely leads to the degradation of the TACI CTF (proteasome of the membrane) <ref type="bibr" target="#b33">(34)</ref> or to the generation of a TACI intracellular domain with signaling function as is the case for a few other described g-secretase substrates [e.g., Notch <ref type="bibr" target="#b34">(35)</ref>].</s><s>Inhibition of g-secretase increased ligandindependent NF-kB activation mediated by TACI-D-Ecto in transfected HEK293T cells.</s><s>We speculate that cleavage of the TACI CTF by g-secretase also takes place in primary B cells, thereby restricting TACI-mediated NF-kB activation after shedding of the ectodomain.</s><s>However, formal proof for this hypothesis is lacking at the moment.</s></p><p><s>Previous work with TACI 2/2 mice and common variable immunodeficiency patients revealed a dual role of TACI in B cell homeostasis <ref type="bibr" target="#b14">(15)</ref><ref type="bibr" target="#b15">(16)</ref><ref type="bibr" target="#b16">(17)</ref><ref type="bibr" target="#b17">(18)</ref><ref type="bibr" target="#b18">(19)</ref>. On the one hand, TACI promotes IgG and IgA class-switch recombination <ref type="bibr" target="#b17">(18,</ref><ref type="bibr" target="#b35">36)</ref>, maintains Ab production <ref type="bibr" target="#b17">(18,</ref><ref type="bibr" target="#b18">19)</ref>, and increases survival of malignant B cells <ref type="bibr" target="#b36">(37)</ref>.</s><s>On the other hand, TACI has negative regulatory effects on B cells, because TACI-deficient mice show a high number of hyperreactive B cells resulting in autoimmunity and lymphoma development <ref type="bibr" target="#b14">(15)</ref><ref type="bibr" target="#b15">(16)</ref><ref type="bibr" target="#b16">(17)</ref>.</s><s>Mechanisms that might contribute to this negative regulatory effect include: 1) TACI-mediated induction of BLIMP-1, which orchestrates the switch from B cell proliferation to plasma cell differentiation (38); 2) involvement of TACI in activationinduced cell death of marginal zone B cells <ref type="bibr" target="#b38">(39)</ref>; and 3) the role of TACI in central removal of autoreactive B cells <ref type="bibr" target="#b39">(40)</ref>.</s><s>We propose that the release of endogenous sTACI contributes to these negative regulatory features of TACI, because the decoy functions of sTACI reduce BAFF-and APRIL-mediated survival of different B cell subpopulations.</s></p><p><s>We found sTACI to interact homotypically, analogously to membrane-bound TACI that preassembles as an oligomeric complex prior to ligand binding <ref type="bibr" target="#b11">(12)</ref>.</s><s>Oligomerization increases the binding avidity for ligands, so that the oligomeric structure of sTACI suggests a functionally relevant decoy activity.</s><s>The fusion protein TACI-Fc (atacicept), which is used in clinical trials, is dimerized via its Fc domain <ref type="bibr" target="#b40">(41)</ref>.</s><s>We compared endogenous sTACI with the pharmacological agent TACI-Fc in ELISAs analyzing the binding of BAFF and APRIL, in NF-kB reporter assays and in survival assays with primary B cells.</s><s>These experiments showed that endogenous sTACI and TACI-Fc share essential decoy functions.</s><s>TACI-Fc (atacicept) reduced Ig levels and mature B cell counts in clinical studies <ref type="bibr" target="#b8">(9)</ref>.</s><s>All of this suggests that endogenous sTACI is a similar negative regulator of the B cell compartment in vivo.</s><s>We propose that an equilibrium of sTACI and BAFF controls B cell numbers fitting to the observation of raised BAFF levels and increased survival of naive B cells in TACI 2/2 mice <ref type="bibr" target="#b14">(15,</ref><ref type="bibr" target="#b15">16)</ref>.</s></p><p><s>We analyzed sTACI levels in patients with systemic and compartmentalized systemic autoimmune diseases.</s><s>Our data indicate that sTACI is produced by locally or systemically accumulating activated B cells and plasma cells.</s><s>In SLE, sTACI was elevated in serum.</s><s>This can readily be explained by a hyperactivation of the B cell compartment and increased levels of circulating plasma cells in SLE <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b41">42)</ref>.</s><s>Interestingly, in SLE, we observed a close correlation of sTACI levels with disease activity.</s><s>This suggests that sTACI might serve as a useful biomarker (e.g., for individualizing [and thereby optimizing] B cell-targeting therapies).</s><s>In a phase II clinical trial investigating the effects of belimumab in SLE patients, patients with high concentrations of anti-nuclear Abs and anti-dsDNA Abs responded better to treatment <ref type="bibr" target="#b42">(43)</ref>.</s><s>However, baseline BAFF values did not correlate with treatment response <ref type="bibr" target="#b43">(44)</ref>.</s><s>Whether sTACI helps to identify patients who are likely to benefit from belimumab or other B cell-directed therapies remains to be studied.</s><s>In MS, sTACI was not increased in blood, but elevated in CSF, in which levels correlated with intrathecal Ig production.</s><s>Natalizumab treatment decreased sTACI levels in the CSF, fitting to the concept that natalizumab prevents entry of VLA-4 + lymphocytes into the CNS, including circulating B cells that express substantial levels of VLA-4 <ref type="bibr" target="#b44">(45)</ref>.</s><s>The fact that atacicept increased disease activity in MS patients <ref type="bibr" target="#b8">(9)</ref>, whereas in SLE, it showed beneficial clinical effects <ref type="bibr" target="#b9">(10)</ref>, remains incompletely understood.</s><s>Expression of BAFF receptor on neurons was observed <ref type="bibr" target="#b45">(46)</ref>.</s><s>So one could speculate that atacicept could limit neuronal survival by decreasing BAFF levels.</s><s>Furthermore, BAFF was shown to induce IL-10-producing regulatory B cells that are able to inhibit T cell proliferation.</s><s>This induction was blocked by TACI-Fc <ref type="bibr" target="#b9">(10)</ref>.</s><s>Therefore, TACI-Fc could interfere in the equilibrium between sTACI and BAFF involved in fine-tuning the balance between effector B cells and regulatory B cells.</s></p><p><s>In summary, the discovery of the existence of sTACI and its effects as a negative immunoregulator extends our understanding of the complexity of the BAFF-APRIL system.</s><s>Our study unravels the biochemical basis of sTACI generation.</s><s>Further, we show that sTACI offers potential as a novel biomarker in MS and SLE and may be useful for therapy optimization.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>All patient samples were collected following written informed consent according to local ethics policy guidelines in Stockholm, Berlin, and Munich and the Declaration of Helsinki.</s><s>We analyzed the following samples: cerebrospinal fluid (CSF) from 37 untreated MS patients (clinically isolated syndrome [CIS]: n = 10; relapsing-remitting multiple sclerosis [RR-MS]: n = 20; and secondary progressive multiple sclerosis [SP-MS]: n = 7) and from 20 untreated patients with other neurologic diseases (ONDs) (sensory symptoms: n = 7; cerebrovascular disease: n = 1; migraine: n = 1; vertigo: n = 1; syringomyelia: n = 1; spinal stenosis: n = 1; neurasthenia: n = 1; alcohol-related spastic paraparesis: n = 1; hearing deficit: n = 1; depression and idiopathic pain: n = 1; fatigue: n = 1; bipolar disorder: n = 1; schizophrenia: n = 1; and diplopia: n = 1); plasma from 57 untreated MS patients (CIS: n = 18; RR-MS: n = 23; and SP-MS: n = 16) and 18 untreated patients with ONDs; CSF from 25 MS patients before and 12 mo after treatment with natalizumab; serum from 17 untreated SLE patients and 22 treated SLE patients (treatment included prednisolone, chloroquine, azathioprine, cyclophosphamide, mycophenolate mofetil, and methotrexate); serum samples of 10 patients prior and after treatment with corticosteroids; and serum from 33 healthy volunteers.</s><s>Intrathecal IgG production was calculated as: IgG-index (CSF IgG/CSF albumin)/(serum IgG/serum albumin).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>FIGURE 1 .</head><label>1</label><figDesc><div><p><s>FIGURE 1. sTACI is released by activated B cells and closely correlates with membrane-bound TACI.</s><s>(A and B) Human purified B cells were activated using CD40L, IL-21, CD40L + IL-21, CpG (ODN2006), anti-IgM, anti-IgM + IL-21, R848, IL-2, and R848 + IL-2 for 4 d.</s><s>(A) TACI surface expression was determined by FACS 4 d after activation.</s><s>Filled histograms represent the isotype control; solid lines the TACI expression.</s><s>(B) sTACI and IgG production were analyzed by ELISA.</s><s>(C) Mean fluorescence intensity (MFI) of TACI surface expression was calculated by subtracting the isotype fluorescence signal.</s><s>sTACI production and MFI of membrane-bound TACI correlated strongly (p = 0.0105, r = 0.7818 Spearman correlation).</s><s>Representative data of two different donors.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>FIGURE 2 .</head><label>2</label><figDesc><div><p><s>FIGURE 2. sTACI is composed of the extracellular part of TACI.</s><s>(A) sTACI was immunoprecipitated from supernatant of HEK293T cells transfected with TACI-FL or an empty vector as control (IP: MAB174) followed by SDS-PAGE and Western blotting (WB).</s><s>IP eluates were probed for TACI (MAB174).</s><s>Silver staining was performed after IP from supernatant of HEK293T cells transfected with full-length TACI or an empty vector as control (IP: AF174).</s><s>(B) After IP of sTACI from HEK293T cell supernatant, the band corresponding to sTACI in silver staining was excised and digested with trypsin or chymotrypsin.</s><s>IP of sTACI from Raji cell supernatant followed by acidic elution and digestion with trypsin or GluC was performed.</s><s>The amino acid sequences of TACI and peptides identified by mass spectrometry after tryptic (green), chymotryptic (blue), or GluC (orange) digestion are shown.</s><s>sTACI derived from HEK293T cells was additionally analyzed by N-terminal sequencing (Edman) (red).</s></p></div></figDesc><graphic coords="6,249.05,50.97,171.22,99.14" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>FIGURE 3 .</head><label>3</label><figDesc><div><p><s>FIGURE 3. ADAM10 sheds TACI.</s><s>(A and B) Raji cells were treated for 24 h with the indicated concentrations of DAPT, C3, TAPI-1, GI354023X, and TAPI-1 + GI354023X.</s><s>(A) sTACI release was determined by ELISA (combined data of four independent experiments [mean 6 SEM]).</s><s>(B) TACI surface expression was analyzed by FACS.</s><s>Only the high inhibitor concentrations with corresponding vehicle control and isotype controls are depicted (representative data of four independent experiments).</s><s>(C-E) Raji cells were lentivirally transduced with two different shRNAs targeting ADAM9, ADAM10, ADAM17, and ADAM19, respectively, or a nontargeting shRNA (Con).</s><s>For comparison, cells were treated with TAPI-1.</s><s>(C) TACI surface expression was analyzed by FACS; representative data of two independent experiments.</s><s>(D) sTACI release was determined by ELISA and controlled for cell number (twotailed, paired t test, including two technical replicates of the respective experiments); combined data of two independent experiments (mean 6 SEM).</s><s>(E) Knockdown of ADAM9, ADAM10, ADAM17, and ADAM19 was determined by quantitative PCR; 1 and 2 represent two different shRNAs targeting the same ADAM; combined data of two independent experiments (mean 6 SEM).</s><s>**p , 0.01, ***p , 0.001.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>FIGURE 4 .</head><label>4</label><figDesc><div><p><s>FIGURE 4. g-Secretase degrades the CTF of TACI shutting down NF-kB activation.</s><s>(A) HEK293T cells were transfected with TACI-FL with a C-terminal FLAG-tag and treated with the indicated concentrations of DAPT or vehicle control.</s><s>After 48 h, lysates were obtained for SDS-PAGE and Western blotting.</s><s>Lysates were probed for expression of tagged TACI demonstrating TACI-FL and the CTF of TACI (representative data of three independent experiments).</s><s>Relative intensities are depicted below the bands.</s><s>(B) HEK293T cells were transfected with 1 ng of TACI-FL or TACI-D-Ecto and luciferase-based NF-kB reporter.</s><s>DAPT (1 mM) and BAFF (100 ng/ml) were added as indicated, and NF-kB activation was determined (two-tailed, paired t tests); combined data of five independent experiments (mean 6 SEM).</s><s>*p , 0.05, **p , 0.01.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>FIGURE 7 .</head><label>7</label><figDesc><div><p><s>FIGURE 7. sTACI as a biomarker.</s><s>(A-E) sTACI levels were determined by ELISA in CSF or serum; horizontal bars indicate the mean.</s><s>(A) sTACI is elevated in the CSF of patients with CIS/MS and NB compared with ONDs (two-tailed, unpaired, and nonparametric t test).</s><s>(B) sTACI in the CSF correlates with intrathecal IgG production (MS/CIS: p , 0.0001, r = 0.75; NB: p = 0.0167, r = 0.9429; OND: NS, Spearman correlation); some data points of OND patients are hidden behind data points of CIS/MS and NB patients.</s><s>(C) sTACI levels in CSF decrease after 12 mo of natalizumab treatment (n = 25) (two-tailed, paired t test).</s><s>(D) sTACI is elevated in the serum of untreated SLE patients and less prominent also in the treated SLE cohort compared with healthy controls (HC; two-tailed, unpaired, and nonparametric t test); with treatment, sTACI levels decrease compared with the untreated SLE patients (two-tailed, unpaired, and nonparametric t test).</s><s>(E) sTACI in serum of untreated SLE patients correlates strongly with disease activity quantified by the SLE Disease Activity Index (SLEDAI; p = 0.0019; r = 0.697, Spearman correlation).</s><s>*p , 0.05, **p , 0.01, ***p , 0.001, ****p , 0.0001.</s></p></div></figDesc></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">by guest on May 17, 2022 http://www.jimmunol.org/ Downloaded from</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">ADAM10 RELEASES SOLUBLE TACI FROM B CELLS by guest on May 17, 2022 http://www.jimmunol.org/ Downloaded from</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">The Journal of Immunology</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>We thank H. R€ ubsamen for excellent technical assistance and Dr. Gurumoorthy Krishnamoorthy and Dr. Naoto Kawakami for critical comments on the manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Disclosures</head><p><s>The authors have no financial conflicts of interest.</s></p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">B-lymphocyte contributions to human autoimmune disease</title>
		<author>
			<persName><forename type="first">K</forename><surname>Yanaba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Bouaziz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Matsushita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Magro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>St Clair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Tedder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol. Rev</title>
		<imprint>
			<biblScope unit="volume">223</biblScope>
			<biblScope unit="page" from="284" to="299" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Cracking the BAFF code</title>
		<author>
			<persName><forename type="first">F</forename><surname>Mackay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schneider</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Immunol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="491" to="502" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations</title>
		<author>
			<persName><forename type="first">W</forename><surname>Stohl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Metyas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Cheema</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Oamar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Roschke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Hilbert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="3475" to="3486" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">The BAFF/ APRIL system in SLE pathogenesis</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">B</forename><surname>Vincent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Morand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mackay</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Rheumatol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="365" to="373" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">B cells in multiple sclerosis: connecting the dots</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>B€ Udingen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bar-Or</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Zamvil</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Opin. Immunol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="713" to="720" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">B cells and antibodies in multiple sclerosis pathogenesis and therapy</title>
		<author>
			<persName><forename type="first">M</forename><surname>Krumbholz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Derfuss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Meinl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Neurol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="613" to="623" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Krumbholz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Theil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Derfuss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rosenwald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Schrader</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Monoranu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Kalled</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Hess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Serafini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Aloisi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Exp. Med</title>
		<imprint>
			<biblScope unit="volume">201</biblScope>
			<biblScope unit="page" from="195" to="200" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">B-cell depletion with rituximab in relapsing-remitting multiple sclerosis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Hauser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Waubant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Arnold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Vollmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Antel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bar-Or</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Panzara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sarkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Agarwal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">358</biblScope>
			<biblScope unit="page" from="676" to="688" />
			<date type="published" when="2008">2008</date>
		</imprint>
		<respStmt>
			<orgName>HERMES Trial Group</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<author>
			<persName><forename type="first">L</forename><surname>Kappos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">P</forename><surname>Hartung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Freedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Boyko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Rad€ U</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Mikol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lamarine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hyvert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Freudensprung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Plitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Van Beek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Atacicept in multiple sclerosis (ATAMS): a randomised</title>
				<imprint>
			<date type="published" when="2014">2014</date>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="353" to="363" />
		</imprint>
		<respStmt>
			<orgName>ATAMS Study Group</orgName>
		</respStmt>
	</monogr>
	<note>placebo-controlled, double-blind, phase 2 trial</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)</title>
		<author>
			<persName><forename type="first">D</forename><surname>Isenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gordon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Licu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Copt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Rossi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wofsy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Rheum. Dis</title>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PII: annrheumdis-2013-205067</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Regulated expression of BAFF-binding receptors during human B cell differentiation</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Darce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Arendt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Jelinek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Immunol</title>
		<imprint>
			<biblScope unit="volume">179</biblScope>
			<biblScope unit="page" from="7276" to="7286" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID)</title>
		<author>
			<persName><forename type="first">L</forename><surname>Garibyan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Lobito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Siegel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Call</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Wucherpfennig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Geha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Invest</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="1550" to="1557" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">NF-AT activation induced by a CAMLinteracting member of the tumor necrosis factor receptor superfamily</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">U</forename><surname>B€ Ulow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Bram</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="page" from="138" to="141" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">Z</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Treanor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Senaldi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Khare</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Boone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kelley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Theill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Colombero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Solovyev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Exp. Med</title>
		<imprint>
			<biblScope unit="volume">192</biblScope>
			<biblScope unit="page" from="137" to="143" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor</title>
		<author>
			<persName><forename type="first">D</forename><surname>Seshasayee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Valdez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Dixit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Tumas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Grewal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="279" to="288" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Activation and accumulation of B cells in TACI-deficient mice</title>
		<author>
			<persName><forename type="first">M</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Roose-Girma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Erickson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Tumas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Grewal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Dixit</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Immunol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="638" to="643" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Regulation of the T-independent humoral response by TACI</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">U</forename><surname>B€ Ulow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Van Deursen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Bram</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="573" to="582" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">TACI is mutant in common variable immunodeficiency and IgA deficiency</title>
		<author>
			<persName><forename type="first">E</forename><surname>Castigli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Garibyan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rachid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bonilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Geha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="829" to="834" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans</title>
		<author>
			<persName><forename type="first">U</forename><surname>Salzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Chapel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Webster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Pan-Hammarstro ¨m</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schmitt-Graeff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schlesier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Peter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Rockstroh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Scha ¨ffer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="820" to="828" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Molecular mechanisms of soluble cytokine receptor generation</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Levine</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">283</biblScope>
			<biblScope unit="page" from="14177" to="14181" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">The &quot;a disintegrin and metalloprotease&quot; (ADAM) family of sheddases: physiological and cellular functions</title>
		<author>
			<persName><forename type="first">K</forename><surname>Reiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Saftig</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Semin. Cell Dev. Biol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="126" to="137" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases</title>
		<author>
			<persName><forename type="first">S</forename><surname>Xanthoulea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pasparakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kousteni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Brakebusch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wallach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lassmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kollias</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Exp. Med</title>
		<imprint>
			<biblScope unit="volume">200</biblScope>
			<biblScope unit="page" from="367" to="376" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site</title>
		<author>
			<persName><forename type="first">J</forename><surname>M€ Ullberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Oberth€ Ur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lottspeich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Mehl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Dittrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Graeve</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Heinrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rose-John</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Immunol</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page" from="4958" to="4968" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Signal peptide peptidases and gamma-secretase: cousins of the same protease family?</title>
		<author>
			<persName><forename type="first">R</forename><surname>Fluhrer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Haass</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurodegener. Dis</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="112" to="116" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Regulated intramembrane proteolysis-lessons from amyloid precursor protein processing</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Lichtenthaler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Haass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Steiner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurochem</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="779" to="796" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Gibb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">El</forename><surname>Shikh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Rowe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">El</forename><surname>Sayed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cichy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yagita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Tew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Dempsey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Crawford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Conrad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Exp. Med</title>
		<imprint>
			<biblScope unit="volume">207</biblScope>
			<biblScope unit="page" from="623" to="635" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Real-time in vivo analysis of T cell activation in the central nervous system using a genetically encoded calcium indicator</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mues</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Bartholoma ¨us</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Thestrup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Griesbeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wekerle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kawakami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Krishnamoorthy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Med</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="778" to="783" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Kuhn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Dislich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Colombo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Zeitschel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Ellwart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kremmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rossner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Lichtenthaler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO J</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="3020" to="3032" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ludwig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hundhausen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Lambert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Broadway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Andrews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Bickett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Leesnitzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Becherer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Comb. Chem. High Throughput Screen</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="161" to="171" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Structure-based design of potent and selective cell-permeable inhibitors of human beta-secretase (BACE-1)</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Stachel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Coburn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Steele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Loutzenhiser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Gregro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Rajapakse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Lai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Crouthamel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="6447" to="6450" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Ryan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Thomas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Gen. Virol</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="2727" to="2732" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme</title>
		<author>
			<persName><forename type="first">P</forename><surname>Reddy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Slack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Cerretti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Kozlosky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Blanton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Shows</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Peschon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Black</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="14608" to="14614" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">ADAMs: key components in EGFR signalling and development</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Blobel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Mol. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="32" to="43" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Gamma-secretase: proteasome of the membrane?</title>
		<author>
			<persName><forename type="first">R</forename><surname>Kopan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">X</forename><surname>Ilagan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Mol. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="499" to="504" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">The presenilins in Alzheimer&apos;s diseaseproteolysis holds the key</title>
		<author>
			<persName><forename type="first">C</forename><surname>Haass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">De</forename><surname>Strooper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">286</biblScope>
			<biblScope unit="page" from="916" to="919" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88</title>
		<author>
			<persName><forename type="first">B</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Santamaria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cols</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Puga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Shan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Xiong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Bussel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chiu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Immunol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="836" to="845" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Chronic lymphocytic leukemia disease progression is accelerated by APRIL-TACI interaction in the TCL1 transgenic mouse model</title>
		<author>
			<persName><forename type="first">V</forename><surname>Lascano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Guadagnoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Schot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Luijks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Guikema</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Cameron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hahne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pals</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Slinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Kipps</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="page" from="3960" to="3963" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">TACI deficiency impairs sustained Blimp-1 expression in B cells decreasing long-lived plasma cells in the bone marrow</title>
		<author>
			<persName><forename type="first">S</forename><surname>Tsuji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cortesa ˜o</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Bram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Platt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cascalho</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="5832" to="5839" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">The TACI receptor regulates T-cell-independent marginal zone B cell responses through innate activation-induced cell death</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Figgett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Fairfax</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">B</forename><surname>Vincent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Le Page</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Katik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Deliyanti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Quah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Verma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Grumont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gerondakis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="573" to="583" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">CVID-associated TACI mutations affect autoreactive B cell selection and activation</title>
		<author>
			<persName><forename type="first">N</forename><surname>Romberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Chamberlain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Saadoun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gentile</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kinnunen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Ng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Virdee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Menard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Cantaert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Morbach</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Invest</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="4283" to="4293" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology</title>
		<author>
			<persName><forename type="first">C</forename><surname>Huang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Opin. Biotechnol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="692" to="699" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Jacobi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Odendahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Reiter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bruns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Burmester</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Radbruch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Valet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Lipsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Do</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="1332" to="1342" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Wallace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Stohl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Furie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Lisse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Mckay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Merrill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Petri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Ginzler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Chatham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Mccune</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="1168" to="1178" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus</title>
		<author>
			<persName><forename type="first">W</forename><surname>Stohl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Hiepe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Latinis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Scheinberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Aranow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">R</forename><surname>Wellborne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Abud-Mendoza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Hough</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="2328" to="2337" />
			<date type="published" when="2012">2012</date>
		</imprint>
		<respStmt>
			<orgName>BLISS-52 Study Group</orgName>
		</respStmt>
	</monogr>
	<note type="report_type">BLISS-76 Study Group</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Natalizumab effects on immune cell responses in multiple sclerosis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Niino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bodner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Simard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Alatab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Trigueiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Racicot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gue ´rette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Antel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="748" to="754" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">BAFF controls neural cell survival through BAFF receptor</title>
		<author>
			<persName><forename type="first">S</forename><surname>Tada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yasui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Nakatsuji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Okuno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Koda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mochizuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sakoda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kikutani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e70924</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
